iPSC Derivation Protocol from Fibroblast in Chemically Defined Medium
GUIDELINE
Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), have the potential to become the source materials for cell-based therapy. Derivation and maintenance conditions have a critical role in determining the iPSC quality, mainly due to the involvement of animal products and feeder cells. We developed a simple procedure to derive and maintain hiPSCs in chemically defined media.
METHODS
- Pour cold 12 ml of DMEM/F12 into a conical tube, and use 1.5 ml to resuspend 2 mg frozen Matrigel with a 5 ml pipet. Matrigel should be in the freezer right before the experiment. Rinse the Matrigel tube again with the same media.
- Mix the Matrigel well, plate 1 ml in each well, and shake well to cover all the surfaces. Leave the plate at room temperature or 37°C for at least 30 minutes. Or coat overnight at 4°C.
- Add 500 μl 0.5 M EDTA and 0.9 g NaCl into 500 ml Calcium/Magnesium free PBS. Sterilize by filtration, and store at 4°C.
- Take low passage # fibroblast culture and plate in 1 well of a 6-well dish so that cells will be about 80% confluent the next day (100K or 150K cells/well) in fibroblast media (usually 10% FBS and Pen/Strep, L-glut, NEAA in DMEM).
- Thaw the four Sendai viruses on ice, mix them, and drop-wisely add them to the cells. Incubate at 37°C.
- If cells look good in the morning and are nearly confluent, prepare plates for splitting. Coat 6 well plates with Matrigel.
- Pass reprogramming well using TryPLE. Incubate for 5 min in an incubator, then wash off the plate and dilute with fibroblast media.
- Spin cells down and resuspend in fibroblast media. Plate on Matrigel (1 well of infected cells into 2×6 well plates coated with Matrigel), also in Reprogramming Medium I. Keep cells in Reprogramming Medium I, feeding them every other day for 3-5 days.
- Change media to Reprogramming Medium II, and 100 μM Sodium Butyrate can be added to improve reprogramming efficiency. Continue feeding every other day.
- Prepare a 24-well plate by coating it with Matrigel. After coating, add E8 (TGFβ1 media) with 1×Rock inhibitor added to each well. Find colonies under scope with 4× objective. Using P20 with tip, circle the colony until it is loosened from surrounding cells. Then use a pipet to push the colony off the plate and suck it into the pipette. Transfer colony pieces into 1 well on the 24-well plate.
- Repeat with other colonies. The day after picking, change media to E8 (TGFb1) without rock inhibitor. Feed daily until the colony is big enough to pass.
- When the colony is ready to pass, use EDTA to pass and leave some of the cells in the original well of the 24 well while transferring most to a new Matrigel-coated well on a 12 or 6-well plate.
- When expanding each colony, keep track of passage number (picking into 24 wells is passage 1). Once you have a well in a 6 well ready to pass, freeze 2 vials down and leave some cells in the well to continue to grow them.
Creative Bioarray Relevant Recommendations
- Creative Bioarray enables research applications by providing iPSCs, iPSC-derived cells, and gene-edited iPSCs. Our expertise includes reprogramming donor cells into iPSCs, editing genes of interest, differentiating them into all major cell subtypes, and validating their phenotype-related function and pharmacology.
NOTES
Some lines do not come off the plate well with TryPLE, with those lines, you may want to wash the plate 2× with EDTA before adding TryPLE.
RELATED PRODUCTS & SERVICES
For research use only. Not for any other purpose.
Resources
- FAQ
- Protocol
- Cell Culture Guide
- Technical Bulletins
-
Explore & Learn
-
Cell Biology
- Monocytes vs. Macrophages
- How to Detect and Remove Endotoxins in Biologics?
- Comparison of Different Methods to Measure Cell Viability
- Contamination of Cell Cultures & Treatment
- Generation and Applications of Neural Stem Cells
- Stem Cell Markers
- Quantification of Cytokines
- Comparison of the MSCs from Different Sources
- T Cell Activation and Expansion
- How to Isolate and Analyze Tumor-Infiltrating Leukocytes?
- Guidelines for Cell Banking to Ensure the Safety of Biologics
- Cell Cryopreservation Techniques and Practices
- What Are Myeloid Cell Markers?
- How to Start Your Culture: Thawing Frozen Cells
- Biomarkers and Signaling Pathways in Tumor Stem Cells
- Techniques for Cell Separation
- Circulating Tumor Cells as Cancer Biomarkers in the Clinic
- CFU Assay for Hematopoietic Cell
- What Is Cell Proliferation and How to Analyze It?
- Direct vs. Indirect Cell-Based ELISA
- Critical Quality Attributes and Assays for Induced Pluripotent Stem Cells
- Comparison of Several Techniques for the Detection of Apoptotic Cells
- STR Profiling—The ID Card of Cell Line
- How to Assess the Migratory and Invasive Capacity of Cells?
- Mesenchymal Stem Cells: A Comprehensive Exploration
- What Cell Lines Are Commonly Used in Biopharmaceutical Production?
- What are the Differences Between M1 and M2 Macrophages?
- Enrichment, Isolation and Characterization of Circulating Tumor Cells (CTCs)
- Cryopreservation of Cells Step by Step
- What are PBMCs?
- Neural Differentiation from Induced Pluripotent Stem Cells
- Isolation, Expansion, and Analysis of Natural Killer Cells
- Tumor Stem Cells: Identification, Isolation and Therapeutic Interventions
- Multi-Differentiation of Peripheral Blood Mononuclear Cells
- Tips For Cell Cryopreservation
- How to Decide Between 2D and 3D Cell Cultures?
- Organoid Differentiation from Induced Pluripotent Stem Cells
- Human Primary Cells: Definition, Assay, Applications
- What are Mesothelial Cells?
- How to Scale Up Single-Cell Clones?
- T Cell, NK Cell Differentiation from Induced Pluripotent Stem Cells
- Cell Culture Medium
- Major Problems Caused by the Use of Uncharacterized Cell Lines
- IL-12 Family Cytokines and Their Immune Functions
- Unveiling the Molecular Secrets of Adipogenesis in MSCs
- Troubleshooting Cell Culture Contamination: A Comprehensive Guide
- CHO Cell Line Development
- Strategies for Enrichment of Circulating Tumor Cells (CTCs)
- How to Eliminate Mycoplasma From Cell Cultures?
- How to Isolate PBMCs from Whole Blood?
- How to Handle Mycoplasma in Cell Culture?
- Spheroid vs. Organoid: Choosing the Right 3D Model for Your Research
- From Collection to Cure: How ACT Works in Cancer Immunotherapy
- Cell-Based High-Throughput Screening Techniques
- Overview of Cell Apoptosis Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- Optimization Strategies of Cell-Based Assays
- Cell Immortalization Step by Step
- Adherent and Suspension Cell Culture
- Live Cell Imaging: Unveiling the Dynamic World of Cellular Processes
- What Are CAR T Cells?
- Cell Viability, Proliferation and Cytotoxicity Assays
- From Blur to Clarity: Solving Resolution Limits in Live Cell Imaging
- Immunogenicity Testing: ELISA and MSD Assays
- Cultivated Meat: What to Know?
- 3D-Cell Model in Cell-Based Assay
- Eosinophils vs. Basophils vs. Neutrophils
- Key Techniques in Primary, Immortalized and Stable Cell Line Development
- From Primary to Immortalized: Navigating Key Cell Lines in Biomedical Research
- Optimization Strategies of Cell-Based Assays
- 3D-Cell Model in Cell-Based Assay
- What Are the Pros and Cons of Adoptive Cell Therapy?
- How to Maximize Efficiency in Cell-Based High-Throughput Screening?
- Role of Cell-Based Assays in Drug Discovery and Development
- What are White Blood Cells?
- Types of Cell Therapy for Cancer
- Immunogenicity Testing: ELISA and MSD Assays
- Understanding Immunogenicity Assays: A Comprehensive Guide
- A Complete Guide to Immortalized Cancer Cell Lines in Cancer Research
- Exploring Cell Dynamics: Migration, Invasion, Adhesion, Angiogenesis, and EMT Assays
- Mastering Cell Culture and Cryopreservation: Key Strategies for Optimal Cell Viability and Stability
-
Histology
- Fluorescent Nuclear Staining Dyes
- Stains Used in Histology
- Troubleshooting in Fluorescent Staining
- Immunohistochemistry Controls
- Overview of the FFPE Cell Pellet Product Lines
- Tips for Choosing the Right Protease Inhibitor
- Comparison of Membrane Stains vs. Cell Surface Stains
- Microscope Platforms
- How to Apply NGS Technologies to FFPE Tissues?
- Overview of Common Tracking Labels for MSCs
- Multiple Animal Tissue Arrays
- Immunohistochemistry Troubleshooting
- Cell and Tissue Fixation
- Cell Lysates: Composition, Properties, and Preparation
- Mitochondrial Staining
- Guides for Live Cell Imaging Dyes
- Instructions for Tumour Tissue Collection, Storage and Dissociation
- How to Choose the Right Antibody for Immunohistochemistry (IHC)
- How to Begin with Multiplex Immunohistochemistry (mIHC)
- Common Immunohistochemistry Stains and Their Role in Cancer Diagnosis
- How Immunohistochemistry Makes the Invisible Brain Visible?
- Histological Staining Techniques: From Traditional Chemical Staining to Immunohistochemistry
- Modern Histological Techniques
- Multiplexing Immunohistochemistry
- What You Must Know About Neuroscience IHC?
- Comparing IHC, ICC, and IF: Which One Fits Your Research?
- From Specimen to Slide: Core Methods in Histological Practice
- Serum vs. Plasma
-
Exosome
- Emerging Technologies and Methodologies for Exosome Research
- How to characterize exosomes?
- Classification, Isolation Techniques and Characterization of Exosomes
- How Important are Lipids in Exosome Composition and Biogenesis?
- Common Techniques for Exosome Nucleic Acid Extraction
- How do PELN Deliver Drugs?
- Current Research Status of Milk Exosomes
- Collection of Exosome Samples and Precautions
- Exosome Size Measurement
- What are the Functions of Exosomal Proteins?
- How to Apply Exosomes in Clinical?
- Production of Exosomes: Human Cell Lines and Cultivation Modes
- Exosomes as Emerging Biomarker Tools for Diseases
- Techniques for Exosome Quantification
- How to Perform Targeted Modification of Exosomes?
- Exosome Transfection for Altering Biomolecular Delivery
- Summary of Approaches for Loading Cargo into Exosomes
- Exosome Antibodies
- Exosome Quality Control: How to Do It?
- Applications of MSC-EVs in Immune Regulation and Regeneration
- How to Enhancement Exosome Production?
- The Role of Exosomes in Cancer
- Unraveling Biogenesis and Composition of Exosomes
- What's the Potential of PELN in Disease Treatment?
- How to Label Exosomes?
- How to Efficiently Utilize MSC Exosomes for Disease Treatment?
-
ISH/FISH
- ISH probe labeling method
- Multiple Approaches to Karyotyping
- Comprehensive Comparison of IHC, CISH, and FISH Techniques
- RNAscope ISH Technology
- What are the Differences between FISH, aCGH, and NGS?
- CARD-FISH: Illuminating Microbial Diversity
- Overview of Common FISH Techniques
- Guidelines for the Design of FISH Probes
- In Situ Hybridization Probes
- Small RNA Detection by ISH Methods
- Comparative Genomic Hybridization and Its Applications
- Overview of Oligo-FISH Technology
- Differences Between DNA and RNA Probes
- How to Use FISH in Hematologic Neoplasms?
- What Is the Use of FISH in Solid Tumors?
- FISH Tips and Troubleshooting
- Multiple Options for Proving Monoclonality
- FISH Techniques for Biofilm Detection
- Whole Chromosome Painting Probes for FISH
- Telomere Length Measurement Methods
- What Types of Multicolor FISH Probe Sets Are Available?
- Different Types of FISH Probes for Oncology Research
- Reagents Used in FISH Experiments
- What are Single, Dual, and Multiplex ISH?
- Mapping of Transgenes by FISH
- ImmunoFISH: Integrates FISH and IL for Dual Detection
- 9 ISH Tips You Can't Ignore
-
Toxicokinetics & Pharmacokinetics
- How to Improve Drug Plasma Stability?
- How Is the Cytotoxicity of Drugs Determined?
- How to Improve the Pharmacokinetic Properties of Peptides?
- Toxicokinetics vs. Pharmacokinetics
- Key Considerations in Toxicokinetic
- Organoids in Drug Discovery: Revolutionizing Therapeutic Research
- What Are Metabolism-Mediated Drug-Drug Interactions?
- Key Factors Influencing Brain Distribution of Drugs
- The Rise of In Vitro Testing in Drug Development
- Predictive Modeling of Metabolic Drug Toxicity
- Effects of Cytochrome P450 Metabolism on Drug Interactions
- How to Improve Drug Distribution in the Brain
- Overview of In Vitro Permeability Assays
- Organ-on-a-Chip Systems for Drug Screening
- Experimental Methods for Identifying Drug-Drug Interactions
- Traditional vs. Novel Drug Delivery Methods
- What factors influence drug distribution?
- How to Design and Synthesize Antibody Drug Conjugates?
- What Is the Role of the Blood-Brain Barrier in Drug Delivery?
- Parameters of Pharmacokinetics: Absorption, Distribution, Metabolism, Excretion
- Physical and Chemical Properties of Drugs and Calculations
- How to Conduct a Bioavailability Assessment?
- What are the Pharmacokinetic Properties of the Antisense Oligonucleotides?
- What Are Compartment Models in Pharmacokinetics?
- Pharmacokinetics Considerations for Antibody Drug Conjugates
- Unraveling the Role of hERG Channels in Drug Safety
- Comparison of MDCK-MDR1 and Caco-2 Cell-Based Permeability Assays
- Methods of Parallel Artificial Membrane Permeability Assays
- Pharmacokinetics of Therapeutic Peptides
- The 8 Costliest Mistakes in Preclinical CYP Phenotyping
- How Are Biomarkers Validated in Drug Development?
- Biomarkers vs. Functional Assays: Closing the Preclinical Gap
- When Should You Introduce ADME Tox Testing in Drug Development?
- How Can You Optimize Drug Toxicity Assessment?
- 6 Easy Steps to Get Your In Vitro ADME Done
- From Cells to Systems: Modern Approaches to Disease Modeling
- How to Choose the Right In Vitro ADME Assays for Small-Molecule Drugs
- What Are Biomarkers in Drug Discovery?
- How Genotoxicity Testing Guides Safer Drug Development
- Top 5 Pitfalls in In Vitro ADME Assays and How to Avoid Them
- 2D vs 3D Cell Culture Models: Which Is Best for Drug Toxicity Testing?
- Troubleshooting Common Issues in Drug Toxicity Testing
- What Is Genotoxicity in Pharmacology? Mechanisms and Sources
- Preclinical Workflow for Drug Toxicity Testing
- In Vitro ADME vs In Vivo ADME
- A Complete Guide to CYP Reaction Phenotyping in 2026
- How to Interpret CYP Phenotyping Data
- Reaction Phenotyping vs. Metabolic Stability
- The 8 Types of Drug Toxicity Every Researcher Must Know
- Why Cardiotoxicity Matters in R&D?
- What Are the Best Methods to Test Cardiotoxicity?
-
Disease Models
- Disease Models of Diabetes Mellitus
- Summary of Advantages and Limitations of Different Oncology Animal Models
- Animal Models of Neurodegenerative Diseases
- What Human Disease Models Are Available for Drug Development?
- Overview of Cardiovascular Disease Models in Drug Discovery
- Why Use PDX Models for Cancer Research?
- Preclinical Models of Acute Liver Failure
- Why Oncology Organoids Fail? How to Build Models That Work
- How to Select the Right Preclinical Model for Drug Development
-
Cell Biology
- Life Science Articles
- Download Center
- Trending Newsletter


